296. Biliary atresia Clinical trials / Disease details


Clinical trials : 71 Drugs : 70 - (DrugBank : 39) / Drug target genes : 35 - Drug target pathways : 60

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05321524
(ClinicalTrials.gov)
July 1, 201518/3/2022Obeticholic Acid in Pediatric Subjects With Biliary AtresiaA Multicenter, Open-Label, Single- and Multiple-Dose, Dose-Finding Study, With an Optional Open-Label Extension to Assess the Safety, Tolerability, and Pharmacokinetics of Obeticholic Acid in Pediatric Subjects With Biliary AtresiaBiliary AtresiaDrug: OCA 0.1mg;Drug: OCA 1.5mg;Drug: OCA 5mgIntercept PharmaceuticalsNULLActive, not recruiting2 Years17 YearsAll32Phase 2Belgium;France;Germany;Israel;Italy;Netherlands;Poland;Spain;United Kingdom